Jonathon Jafari

Biography

 As Senior Director, Business Development, Mr. Jafari has been involved in many of CDRD’s startups, including Kairos Therapeutics (which was sold to Zymeworks), Sitka Biopharma, and Zucara. In addition he is the Chief Business Officer and interim Chief Executive Officer for Sepset Biosciences. Prior to joining CDRD, he spent eight years in progressive business development and strategic marketing roles at QLT Inc. Prior to QLT, Mr. Jafari worked for Eli Lilly in the Business Development Market Assessment group and provided market evaluations and sales forecasts for licensing and M&A opportunities. 

Research Interest

 Mr. Jafari also had research roles at Indiana University in molecular evolution and in tumor targeting at Genetic Therapy Inc., which was a gene therapy company that was acquired by Sandoz, now Novartis. Mr. Jafari received his BSc Biology and MBA from Indiana University and his MSc Biotechnology from Johns Hopkins University.